MEDVi vs Mochi Health: Which GLP-1 Provider Is Better?
A side-by-side comparison of MEDVi and Mochi Health covering pricing, scores, medication types, insurance, and more to help you decide.
Higher Rated
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViMochi Health
#23 of 317.7/10
Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.
Visit Mochi Health| Feature | MEDVi | Mochi Health |
|---|---|---|
| Our Score | 8.3/10 | 7.7/10 |
| Starting Price | $179/mo | $175/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want a tech-forward platform with app-based tracking |
| Ranking | #9 | #23 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Mochi Health
Pros
- +Great app experience
- +Progress tracking
- +Modern platform
- +Good UX
Cons
- −Compounded only
- −No insurance
Our Verdict
MEDVi edges out Mochi Health with a score of 8.3/10 vs 7.7/10. If budget is your priority, Mochi Health starts at $175/mo compared to MEDVi's $179/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking.